Breakthrough pain: Characteristics and impact in patients with cancer pain

Pain

Volumn 81, Issue 1-2, 1999, Pages 129-134

  Portenoy, Russell K ^a   Payne, David ^b   Jacobsen, Paul ^c  

^a BETH ISRAEL MEDICAL CENTER   (United States)

^b North East Structural Genomics Center (NESG)   (United States)

^c H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

Breakthrough pain; Cancer pain; Functional impairment; Incident pain; Opioid therapy; Psychological distress

Indexed keywords

OPIATE;

ADULT; AGED; ARTICLE; CANCER PAIN; DISTRESS SYNDROME; FEMALE; FUNCTIONAL DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADULT; AGED; ANXIETY; CROSS-SECTIONAL STUDIES; DEPRESSION; DISABILITY EVALUATION; FEMALE; HEALTH SURVEYS; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASMS; PAIN; PAIN MEASUREMENT;

EID: 0032899247     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3959(99)00006-8     Document Type: Article

References (14)

1. Agency for Health Care Policy and Research, U.S. Dept. of Health and Human Services: Clinical Practice Guideline Number 9: Management of Cancer Pain. Washington, DC, 1994.
2. Banning A., Sjogren P., Henriksen H. Treatment outcome in a multidisciplinary cancer pain clinic. Pain. 47:1991;129-134.
3. Beck A., Epstein N., Brown G., Steer R. An inventory for measuring anxiety: psychometric properties. J. Consult. Clin. Psychol. 56:1988;893-897.
4. Beck A., Ward C.H., Mendelson M.et al. An inventory for measuring depression. Arch. Gen. Psychiatry. 4:1961;561-671.
5. Bruera E., Schoeller T., Wenk R., MacEachern T., Marcelino S., Hanson J., Suarez-Almazor M. A prospective multi-center assessment of the Edmonton staging system for cancer pain. J. Pain Symptom Manage. 10:1995;348-355.
6. Daut R.L., Cleeland C.S., Flanery R.C. Development of the Wisconsin Brief Pain Questionnaire to assess pain in cancer and other diseases. Pain. 17(2):1983;197-210.
7. Fishman B., Pasternak S., Wallenstein S., Houde R., Holland J.C., Foley K.M. The Memorial Pain Assessment Card: a valid instrument for the assessment of cancer pain. Cancer. 60:1987;1151-1157.
8. Mercadante S., Maddaloni S., Roccella S., Salvaggio L. Predictive factors in advanced cancer pain treated only by analgesics. Pain. 50:1992;151-155.
9. Portenoy R.K., Hagen N.A. Breakthrough pain: definition, prevalence and characteristics. Pain. 41:1990;273-281.
10. Portenoy R.K., Miransky J., Thaler H.T., Hornnung J., Bianchi G., Cibas-Kong I., Feldhamer E., Lewis F., Matamoros I., Sugar M.Z., Olivieri A.P., Kemeny N.E., Foley K.M. Pain in ambulatory patients with lung or colon cancer: prevalence, characteristics and impact. Cancer. 70:1992;1616-1624.
11. Portenoy R.K. Treatment of temporal variations in chronic cancer pain. Semin. Oncol. 24(5):1997;S16-12.
12. Portenoy, R.K., Payne, R., Coluzzi, P., Raschko, W., Lyss, A., Busch, M.A., Frigerio, V., Ingham, J., Loseth, D.B., Nordbrock, E. and Rhiner, M., Oral transmucosal fentanyl citrate (OTFC) for the treatment of breakthrough pain in cancer patients: a controlled dose titration study, Pain, 79(2/3) (1999) 303-312.
13. Serlin R.C., Mendoza T.R., Nakamura Y., Edwards K.R., Cleeland C.S. When is cancer pain mild, moderate or severe? Grading pain severity by its interference with function. Pain. 61(2):1995;277-284.
14. Yates J.W., Chalmer B., McKegney F.P. Evaluation of patients with advanced cancer using the Karnofsky Performance Status. Cancer. 40:1980;2220-2224.